Australia, May 3 -- ARAVIVE Inc., United States of America, has filed an application (2022343188) on Sept. 12, 2022, for 'METHODS OF TREATING LOCALLY ADVANCED OR METASTATIC PANCREATIC ADENOCARCINOMA USING AXL DECOY RECEPTORS AS FIRST-LINE THERAPY.'
Inventor(s): Gail MCINTYRE and Reshma RANGWALA
Application Status: Filed
The original document can be viewed at: http://pericles.ipaustralia.gov.au/ols/auspat/applicationDetails.do?applicationNo=2022343188
Disclaimer: Curated by HT Syndication....